1f
12
9
1a
8
20
8
49
16
8
19
1
49
2
8
1b
1d
18
89
2f
1d
2 29
1d
25
2f
Samuel Alperin, MD
4eAssistant Professor of Clinical Neurology
28
67
3
60
Co-Chair of Section of Community Neurology, CHOP
11
Department: Neurology
4
1
b
1d
46
Contact information
5f
4
3
3
3
2
4
b
1f
5f
3401 Civic Center Blvd
Philadelphia, PA 19104
26
Philadelphia, PA 19104
35
83
Email:
alperins@chop.edu
12
alperins@chop.edu
13
Education:
21 7 BS c
2b Cornell University, 2011.
21 7 MD c
39 Hofstra Northwell Medical School, 2017.
c
3
3
21
21 7 BS c
2b Cornell University, 2011.
21 7 MD c
39 Hofstra Northwell Medical School, 2017.
c
1f
Post-Graduate Training
24 57 Child Neurology Residency, Cincinnati Children's Hospital, 2017-2022.
c
3
25
24 57 Child Neurology Residency, Cincinnati Children's Hospital, 2017-2022.
c
17
Certifications
28 1d ABPN, 2022.
c
3
8d
Permanent link28 1d ABPN, 2022.
c
2 29
21
1e
1d
24
5e
26 29
27
Description of Clinical Expertise
75 Angelman Syndrome, Dup15q Syndrome, 22q11 Deletion Syndrome, 22q11 Duplication Syndrome, Autism, ADHD26 29
23
152 Ihnen SKZ, Alperin S, Capal JK, Cohen AL, Peters JM, Bebin EM, Northrup HA, Sahin M, Krueger DA; TACERN Study Group.: Accumulated seizure burden predicts neurodevelopmental outcome at 36 months of age in patients with tuberous sclerosis complex. Epilepsia Jan 2025.
d6 Samuel Alperin, Sarah E. Hopkins, T. Blaine Crowley, Daniel E. McGinn, Lauren Lairson, Victoria Giunta, Beverly S. Emanuel, Elaine H. Zackai, and Donna M. McDonald-McGinn 6f : Neuroradiologic Findings in 22q11.2 Duplication Syndrome and Comparison to 22q11.2 Deletion Syndrome 4b 22q11 Annual Conference (Portugal 2024) July 2024.
d6 Tyler M. Spivey, Donald L. Gilbert, Samuel Alperin: Neurological Conferences: A Comparison Study. Child Neurology Society 2023 October 2023.
16a Ihnen SK, Alperin S, Capal J, Horn P, Griffith M, Cohen A, Peters J, Warfield S, Kroeck M, Sahin M, Wu J, Bebin M, Northrup, Krueger D: Developmental Profiles in Early-Life Tuberous Sclerosis Complex (TSC). Platform Presentation at 2022 Child Neurology Society in Cincinnati October 2022.
129 Alperin S, Krueger DA, Franz DN, Agricola KD, Stires G, Horn PS, Capal JK.: Symptom rates and profile clustering in tuberous sclerosis complex-associated neuropsychiatric disorders (TAND). J Neurodev Disord 13: 60, Dec 2021.
110 Alperin, S., Krueger, D.A., & Capal J.K.: Tuberous Sclerosis-Associated Neuropsychiatric Disorders at Cincinnati Children’s Hospital. Poster presentation at CNS-ICNA 2020 Meeting(Virtual) Oct 2020.
14c Alperin, S., Clemens, N., Merritt, C., Statile A.M., & Mallon, D.: Implementation of a humanities in medicine curriculum for pediatric residents. Poster Presentation at Association of Pediatric Program Directors' Annual Spring Meeting, San Diego, CA Mar 2020.
180 Silverstein, M.J., Faraone, S.V., Alperin, S., Leon, T.L., Biederman, J., Spencer, T.J., & Adler L.A.: Validation of the expanded versions of the adult ADHD Self-Report Scale v1. 1 Symptom Checklist and the Adult ADHD Investigator Symptom Rating Scale. Journal of Attention Disorders 10(1): 1101-1110, Aug 2019.
1aa Silverstein, M.J., Faraone, S.V., Alperin, S., Biederman, J., Spencer, T.J., & Adler L.A.: How Informative Are Self-Reported Adult Attention-Deficit/Hyperactivity Disorder Symptoms? An Examination of the Agreement Between the Adult Attention-Deficit/Hyperactivity Disorder Self- Report Scale V1.1 and Adult Attention-Deficit/Hyperactivity Disorder Investigator Symptom Rating 6b Scale. Journal of Child and Adolescent Psychopharmacology 28(5): 339-349, Jun 2018.
2c
7
1d
1f
Selected Publications
17d Conley C, Dienes E, He XA, Chao JH, Callahan MJ, Onisei AM, Bennett EE, Stein ALS, Alperin S, Kalin J, Mukerji S, Safavi A, Diaz CD, and Cravero J: Perceived Risk of Imaging Modalities to Evaluate Developmental Delay (PRIMEDD): A Multicenter, Multispecialty Comparison. Anesthesiology (in review) 2025152 Ihnen SKZ, Alperin S, Capal JK, Cohen AL, Peters JM, Bebin EM, Northrup HA, Sahin M, Krueger DA; TACERN Study Group.: Accumulated seizure burden predicts neurodevelopmental outcome at 36 months of age in patients with tuberous sclerosis complex. Epilepsia Jan 2025.
d6 Samuel Alperin, Sarah E. Hopkins, T. Blaine Crowley, Daniel E. McGinn, Lauren Lairson, Victoria Giunta, Beverly S. Emanuel, Elaine H. Zackai, and Donna M. McDonald-McGinn 6f : Neuroradiologic Findings in 22q11.2 Duplication Syndrome and Comparison to 22q11.2 Deletion Syndrome 4b 22q11 Annual Conference (Portugal 2024) July 2024.
d6 Tyler M. Spivey, Donald L. Gilbert, Samuel Alperin: Neurological Conferences: A Comparison Study. Child Neurology Society 2023 October 2023.
16a Ihnen SK, Alperin S, Capal J, Horn P, Griffith M, Cohen A, Peters J, Warfield S, Kroeck M, Sahin M, Wu J, Bebin M, Northrup, Krueger D: Developmental Profiles in Early-Life Tuberous Sclerosis Complex (TSC). Platform Presentation at 2022 Child Neurology Society in Cincinnati October 2022.
129 Alperin S, Krueger DA, Franz DN, Agricola KD, Stires G, Horn PS, Capal JK.: Symptom rates and profile clustering in tuberous sclerosis complex-associated neuropsychiatric disorders (TAND). J Neurodev Disord 13: 60, Dec 2021.
110 Alperin, S., Krueger, D.A., & Capal J.K.: Tuberous Sclerosis-Associated Neuropsychiatric Disorders at Cincinnati Children’s Hospital. Poster presentation at CNS-ICNA 2020 Meeting(Virtual) Oct 2020.
14c Alperin, S., Clemens, N., Merritt, C., Statile A.M., & Mallon, D.: Implementation of a humanities in medicine curriculum for pediatric residents. Poster Presentation at Association of Pediatric Program Directors' Annual Spring Meeting, San Diego, CA Mar 2020.
180 Silverstein, M.J., Faraone, S.V., Alperin, S., Leon, T.L., Biederman, J., Spencer, T.J., & Adler L.A.: Validation of the expanded versions of the adult ADHD Self-Report Scale v1. 1 Symptom Checklist and the Adult ADHD Investigator Symptom Rating Scale. Journal of Attention Disorders 10(1): 1101-1110, Aug 2019.
1aa Silverstein, M.J., Faraone, S.V., Alperin, S., Biederman, J., Spencer, T.J., & Adler L.A.: How Informative Are Self-Reported Adult Attention-Deficit/Hyperactivity Disorder Symptoms? An Examination of the Agreement Between the Adult Attention-Deficit/Hyperactivity Disorder Self- Report Scale V1.1 and Adult Attention-Deficit/Hyperactivity Disorder Investigator Symptom Rating 6b Scale. Journal of Child and Adolescent Psychopharmacology 28(5): 339-349, Jun 2018.
2c